Inhaled Loxapine: A New Treatment for Agitation in Schizophrenia or Bipolar Disorder.
Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.
Drugs Today (Barc). 2013 Mar; 49(3): 195-201
Owen RT
The treatment of acute agitation in psychiatric patients has traditionally involved the use of oral or intramuscular benzodiazepines,… Continue reading
Current Evidence for the Clinical Use of Long-Chain Polyunsaturated N-3 Fatty Acids to Prevent Age-Related Cognitive Decline and Alzheimer’s Disease.
Current evidence for the clinical use of long-chain polyunsaturated N-3 Fatty acids to prevent age-related cognitive decline and Alzheimer’s disease.
J Nutr Health Aging. 2013; 17(3): 240-51
Dacks PA, Shineman DW, Fillit HM
An NIH State of the Science… Continue reading
How Does a Developmental Perspective Inform Us About the Early Natural History of Bipolar Disorder?
How does a Developmental Perspective inform us about the early Natural History of Bipolar Disorder?
Filed under: Depression Treatment
J Can Acad Child Adolesc Psychiatry. 2013 Feb; 22(1): 6-12
Duffy A, Carlson GA
The focus of this paper is… Continue reading
Depression Treatment: Prevalence of Mental Health Disorders Among Low-Income African American Adolescents.
Prevalence of mental health disorders among low-income African American adolescents.
Filed under: Depression Treatment
Soc Psychiatry Psychiatr Epidemiol. 2013 Feb 6;
Byck GR, Bolland J, Dick D, Ashbeck AW, Mustanski BS
PURPOSE: Data on the prevalence of mental health… Continue reading